Advances in developing ACE2 derivatives against SARS-CoV-2-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Advances in developing ACE2 derivatives against SARS-CoV-2

Published:2023-05 Issue:5 Volume:4 Page:e369-e378
ISSN:2666-5247
Container-title:The Lancet Microbe
language:en
Short-container-title:The Lancet Microbe

Author:

Zhang Haoran,Lv Panjing,Jiang Jingrui,Liu Yahui,Yan Ruixi,Shu Sainan,Hu Bing,Xiao Han,Cai Kun,Yuan Shuai,Li Yan

Publisher

Elsevier BV

Subject

Virology,Infectious Diseases,Microbiology (medical),Microbiology

Reference82 articles.

1. Transmission of SARS-CoV-2: a review of viral, host, and environmental factors;Meyerowitz;Ann Intern Med,2021

2. SARS-CoV-2 pathogenesis;Lamers;Nat Rev Microbiol,2022

3. SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact;Lipsitch;Nat Rev Immunol,2022

4. A pneumonia outbreak associated with a new coronavirus of probable bat origin;Zhou;Nature,2020

5. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor;Lan;Nature,2020

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peptide S4 is an entry inhibitor of SARS-CoV-2 infection;Virology;2024-09

2. A nanobody interaction with SARS-COV-2 Spike allows the versatile targeting of lentivirus vectors;Journal of Virology;2024-08-29

3. Lessons learnt from broad-spectrum coronavirus antiviral drug discovery;Expert Opinion on Drug Discovery;2024-07-30

4. Seasonal human coronaviruses OC43, 229E, and NL63 induce cell surface modulation of entry receptors and display host cell-specific viral replication kinetics;Microbiology Spectrum;2024-07-02

5. SARS-CoV-2 evolution has increased resistance to monoclonal antibodies and first-generation COVID-19 vaccines: Is there a future therapeutic role for soluble ACE2 receptors for COVID-19?;Antiviral Research;2024-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3